Showing results (111-120 of 149) with videos related to
Sort By:
Pageof 15
Journal of Neuro-Oncology|January 15, 2018
Neurologic complications of immune checkpoint inhibitorsAvi Fellner, Chen Makranz, Michal Lotem, et al.Breast Cancer Research and Treatment|October 10, 2020
Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcomeMatan Ben-Zion Berliner, Rinat Yerushalmi, Inbar Lavie, et al.Journal of Neuro-Oncology|February 7, 2024
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatmentItamar Averbuch, Roi Tschernichovsky, Shlomit Yust-Katz, et al.Hematological Oncology|June 23, 2017
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survivalErel Joffe, N Ariela Arad, Osnat Bairey, et al.Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.Journal of the Neurological Sciences|November 23, 2019
Echoes from the past- changing associations between brain tumors and ethnicityShlomit Yust-Katz, Aya Bar Oz, Estela Derazne, et al.Anticancer Research|November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in IsraelMichal Inbar, Yair Herishanu, Neta Goldschmidt, et al.European Journal of Haematology|February 9, 2026
Obinutuzumab Maintenance in Follicular Lymphoma Is Associated With Better Progression Free Survival and Comparable ToxicityRenana Robinson, Tamar Berger, Tzippy Shochat, et al.European Journal of Haematology|April 25, 2023
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortalityShlomzion Aumann, Uria Tsubary, Boaz Nachmias, et al.Leukemia Research|June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemiaTamar Tadmor, Ilana Levy, Yair Herishanu, et al.Pageof 15